These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 11408045

  • 1. Negative functional effects of cGMP mediated by cGMP protein kinase are reduced in T4 cardiac myocytes.
    Engel S, Yan L, Weiss H, Scholz P.
    Eur J Pharmacol; 2001 Jun 01; 421(1):23-30. PubMed ID: 11408045
    [Abstract] [Full Text] [Related]

  • 2. Cyclic GMP reduces ventricular myocyte stunning after simulated ischemia-reperfusion.
    Gandhi A, Yan L, Scholz PM, Huang MW, Weiss HR.
    Nitric Oxide; 1999 Dec 01; 3(6):473-80. PubMed ID: 10637126
    [Abstract] [Full Text] [Related]

  • 3. Cyclic GMP protein kinase activity is reduced in thyroxine-induced hypertrophic cardiac myocytes.
    Yan L, Zhang Q, Scholz PM, Weiss HR.
    Clin Exp Pharmacol Physiol; 2003 Dec 01; 30(12):943-50. PubMed ID: 14678234
    [Abstract] [Full Text] [Related]

  • 4. Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy.
    Zhang Q, Goel N, Rodriguez R, Scholz PM, Weiss HR.
    Eur J Pharmacol; 2006 May 10; 537(1-3):45-51. PubMed ID: 16626695
    [Abstract] [Full Text] [Related]

  • 5. Interaction between cyclic GMP protein kinase and cyclic AMP may be diminished in stunned cardiac myocytes.
    Yan L, Patel KN, Zhang Q, Scholz PM, Weiss HR.
    Eur J Pharmacol; 2001 Aug 24; 426(1-2):11-9. PubMed ID: 11525765
    [Abstract] [Full Text] [Related]

  • 6. Effects of cyclic GMP and its protein kinase on the contraction of ventricular myocytes from hearts after cardiopulmonary arrest.
    Su J, Scholz PM, Tse J, Weiss HR.
    Can J Physiol Pharmacol; 2004 Nov 24; 82(11):986-92. PubMed ID: 15644938
    [Abstract] [Full Text] [Related]

  • 7. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
    Moalem J, Davidov T, Zhang Q, Grover GJ, Weiss HR, Scholz PM.
    J Surg Res; 2006 Sep 24; 135(1):38-44. PubMed ID: 16600302
    [Abstract] [Full Text] [Related]

  • 8. Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytes.
    Straznicka M, Gong G, Yan L, Scholz PM, Weiss HR.
    J Cardiovasc Pharmacol; 1999 Aug 24; 34(2):229-36. PubMed ID: 10445674
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide and cGMP protein kinase activity in aged ventricular myocytes.
    Zhang Q, Molino B, Yan L, Haim T, Vaks Y, Scholz PM, Weiss HR.
    Am J Physiol Heart Circ Physiol; 2001 Dec 24; 281(6):H2304-9. PubMed ID: 11709396
    [Abstract] [Full Text] [Related]

  • 10. Opposing functional effects of cyclic GMP and cyclic AMP may act through protein phosphorylation in rabbit cardiac myocytes.
    Yan L, Lee H, Huang MW, Scholz PM, Weiss HR.
    J Auton Pharmacol; 2000 Apr 24; 20(2):111-21. PubMed ID: 11095549
    [Abstract] [Full Text] [Related]

  • 11. Cyclic GMP signaling and regulation of SERCA activity during cardiac myocyte contraction.
    Zhang Q, Scholz PM, He Y, Tse J, Weiss HR.
    Cell Calcium; 2005 Mar 24; 37(3):259-66. PubMed ID: 15670873
    [Abstract] [Full Text] [Related]

  • 12. Cyclic GMP-induced reduction in cardiac myocyte function is partially mediated by activation of the sarcoplasmic reticulum Ca(2+)-ATPase.
    Zhang Q, Yan L, Weiss HR, Scholz PM.
    Pharmacology; 2002 Feb 24; 64(2):106-12. PubMed ID: 11803251
    [Abstract] [Full Text] [Related]

  • 13. Interaction between the opposing functional effects of cyclic AMP and cyclic GMP in hypertrophic cardiac myocytes.
    Patel KN, Yan L, Gandhi A, Scholz PM, Weiss HR.
    Basic Res Cardiol; 2001 Feb 24; 96(1):34-41. PubMed ID: 11215530
    [Abstract] [Full Text] [Related]

  • 14. SERCA inhibition limits the functional effects of cyclic GMP in both control and hypertrophic cardiac myocytes.
    Zhang Q, Davidov T, Weiss HR, Scholz PM.
    Pharmacology; 2009 Feb 24; 83(4):223-30. PubMed ID: 19258738
    [Abstract] [Full Text] [Related]

  • 15. T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium.
    Katz E, Zhang Q, Weiss HR, Scholz PM.
    Peptides; 2006 Sep 24; 27(9):2276-83. PubMed ID: 16762459
    [Abstract] [Full Text] [Related]

  • 16. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
    Meyer M, Zhang Q, Khurana K, Scholz PM, Weiss HR.
    J Cardiovasc Pharmacol; 2007 Feb 24; 49(2):100-5. PubMed ID: 17312451
    [Abstract] [Full Text] [Related]

  • 17. Negative functional effects of cyclic GMP are altered by cyclic AMP phosphodiesterases in rabbit cardiac myocytes.
    Weiss HR, Lazar MJ, Punjabi K, Tse J, Scholz PM.
    Eur J Pharmacol; 2003 Nov 14; 481(1):25-31. PubMed ID: 14637171
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation.
    Taylor MS, Okwuchukwuasanya C, Nickl CK, Tegge W, Brayden JE, Dostmann WR.
    Mol Pharmacol; 2004 May 14; 65(5):1111-9. PubMed ID: 15102939
    [Abstract] [Full Text] [Related]

  • 19. Cyclic GMP reduces myocardial stunning through non-cyclic GMP protein kinase mechanisms.
    Zhang Q, Lazar M, Yan L, He Y, Tse J, Weiss HR, Scholz PM.
    J Cardiovasc Pharmacol; 2004 Aug 14; 44(2):235-43. PubMed ID: 15243306
    [Abstract] [Full Text] [Related]

  • 20. Differential regulation of phospholipase A2 (PLA2)-dependent Ca2+ signaling in smooth muscle by cAMP- and cGMP-dependent protein kinases. Inhibitory phosphorylation of PLA2 by cyclic nucleotide-dependent protein kinases.
    Murthy KS, Makhlouf GM.
    J Biol Chem; 1998 Dec 18; 273(51):34519-26. PubMed ID: 9852121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.